DE3883495T2 - Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung. - Google Patents

Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung.

Info

Publication number
DE3883495T2
DE3883495T2 DE88402944T DE3883495T DE3883495T2 DE 3883495 T2 DE3883495 T2 DE 3883495T2 DE 88402944 T DE88402944 T DE 88402944T DE 3883495 T DE3883495 T DE 3883495T DE 3883495 T2 DE3883495 T2 DE 3883495T2
Authority
DE
Germany
Prior art keywords
amino acid
preparation
therapeutic use
enantiomeric derivatives
enantiomeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88402944T
Other languages
English (en)
Other versions
DE3883495D1 (de
Inventor
Pierre Duhamel
Lucette Duhamel
Denis Danvy
Jean-Christophe Plaquevent
Bruno Giros
Claude Gros
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioprojet SC
Original Assignee
Bioprojet SC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet SC filed Critical Bioprojet SC
Application granted granted Critical
Publication of DE3883495D1 publication Critical patent/DE3883495D1/de
Publication of DE3883495T2 publication Critical patent/DE3883495T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
DE88402944T 1987-11-24 1988-11-24 Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung. Expired - Lifetime DE3883495T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8716239A FR2623498B1 (fr) 1987-11-24 1987-11-24 Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
DE3883495D1 DE3883495D1 (de) 1993-09-30
DE3883495T2 true DE3883495T2 (de) 1993-12-09

Family

ID=9357085

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88402944T Expired - Lifetime DE3883495T2 (de) 1987-11-24 1988-11-24 Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung.

Country Status (7)

Country Link
US (3) US5208255A (de)
EP (1) EP0318377B1 (de)
JP (2) JP2529172B2 (de)
AT (1) ATE93518T1 (de)
DE (1) DE3883495T2 (de)
ES (1) ES2059554T3 (de)
FR (1) FR2623498B1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623498B1 (fr) * 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques
US5223516A (en) * 1990-03-22 1993-06-29 E. R. Squibb & Sons, Inc. 3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same
FR2673105B1 (fr) * 1991-02-26 1995-01-13 Bioprojet Soc Civ Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
FI922867A (fi) * 1991-06-21 1992-12-22 Tanabe Seiyaku Co Dikarbonsyraderivat och foerfarande foer framstaellning av dem
FR2684553B1 (fr) * 1991-12-10 1995-04-07 Bioprojet Soc Civ Nouveaux medicaments pour le traitement de l'hypertension arterielle, de l'insuffisance cardiaque chronique, de l'insuffisance renale et, de maniere generale, d'affections entrainant une retention hydrosodee.
JPH06199850A (ja) * 1992-12-28 1994-07-19 Tanabe Seiyaku Co Ltd インドール含有ペプチド及びその製法
US5760241A (en) * 1995-12-28 1998-06-02 Zambon Group S.P.A. Thiol derivatives with metallopeptidase inhibitory activity
FR2744446B1 (fr) * 1996-02-05 1998-04-17 Bioprojet Soc Civ Procede de synthese asymetrique des derives s-acyles de l'acide 2-mercaptomethyl 3-phenyl propanoique, application a la synthese de derives n-(mercaptoacyl) amino-acides
DE69732570T2 (de) * 1996-08-02 2005-12-29 Kaneka Corp. Sulfonsäureester-derivate, verfahren zu ihrer herstellung und ihre verwendung
EP0937710B1 (de) 1998-02-16 2003-04-16 Ajinomoto Co., Inc. Verfahren zur Herstellung von optisch aktiven Phenylpropionsäure-Derivat
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP2234608A2 (de) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzymhemmer mit metallbindenden teilen in kombination mit targeting-teilen
WO2009077386A1 (en) 2007-12-17 2009-06-25 F. Hoffmann-La Roche Ag Process for synthesis of tritiated and deuterated thiorphan and acetorphan
FR2950362B1 (fr) * 2009-09-21 2011-10-21 Univ Clermont Auvergne Utilisation d'activateurs de canaux potassiques k2p en tant qu'antalgiques.
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
WO2012082857A1 (en) 2010-12-15 2012-06-21 Theravance, Inc. Neprilysin inhibitors
SI2651896T1 (sl) 2010-12-15 2015-11-30 Theravance Biopharma R&D Ip, Llc Inhibitorji neprilizina
CA2825737C (en) 2011-02-17 2018-11-13 Theravance, Inc. Substituted aminobutyric derivatives as neprilysin inhibitors
US8449890B2 (en) 2011-02-17 2013-05-28 Theravance, Inc. Neprilysin inhibitors
CA2835216A1 (en) 2011-05-31 2012-12-06 Theravance, Inc. Neprilysin inhibitors
CN103582630B (zh) 2011-05-31 2016-08-17 施万生物制药研发Ip有限责任公司 脑啡肽酶抑制剂
JP5885832B2 (ja) 2011-05-31 2016-03-16 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ネプリライシン阻害剤
TWI560172B (en) 2011-11-02 2016-12-01 Theravance Biopharma R&D Ip Llc Neprilysin inhibitors
EP2855464B1 (de) 2012-05-31 2016-10-26 Theravance Biopharma R&D IP, LLC Stickstoffoxiddonor als neprilysin-inhibitoren
NZ723772A (en) 2012-06-08 2017-06-30 Theravance Biopharma R&D Ip Llc Neprilysin inhibitors
CN104470521B (zh) 2012-06-08 2017-04-12 施万生物制药研发Ip有限责任公司 脑啡肽酶抑制剂
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
EP2882716B9 (de) 2012-08-08 2018-12-26 Theravance Biopharma R&D IP, LLC Neprilysin hemmer
SI2964616T1 (sl) 2013-03-05 2017-08-31 Theravance Biopharma R&D Ip, Llc Zaviralci neprilizina
RU2016135057A (ru) 2014-01-30 2018-03-12 ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи Производные 5-бифенил-4-гетероарилкарбониламинопентановой кислоты в качестве ингибиторов неприлизина
US9593110B2 (en) 2014-01-30 2017-03-14 Theravence Biopharma R&D IP, LLC Neprilysin inhibitors
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
CN107257785B (zh) 2015-02-11 2020-07-07 施万生物制药研发Ip有限责任公司 作为脑啡肽酶抑制剂的(2s,4r)-5-(5’-氯-2’-氟联苯-4-基)-4-(乙氧基草酰基氨基)-2-羟甲基-2-甲基戊酸
EP3259255B1 (de) 2015-02-19 2020-10-21 Theravance Biopharma R&D IP, LLC (2r,4r)-5-(5'-chlor-2'-fluorbiphenyl-4-yl )-2-hydroxy-4-[(5-methyloxazol-2-carbonyl)amino]pentansäure
CN108779084A (zh) 2016-03-08 2018-11-09 施万生物制药研发Ip有限责任公司 结晶型(2s,4r)-5-(5′-氯-2′-氟-[1,1′-联苯]-4-基)-2-(乙氧基甲基)-4-(3-羟基异恶唑-5-甲酰氨基)-2-甲基戊酸和其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4798904A (en) * 1983-10-03 1989-01-17 E. R. Squibb & Sons, Inc. Certain [(lower alkanoyl-thio)methyl-1-oxo-3-phenyl propyl amino]benzene lower alkanoic acid or ester derivatives which inhibit enkephalinase
FR2559770B1 (fr) * 1984-02-20 1986-10-24 Roussel Uclaf Nouveaux derives de n-alkyl-o-mercaptopropanamide, leurs procedes de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
US4740499A (en) * 1986-07-28 1988-04-26 Monsanto Company Method of enhancing the bioactivity of atrial peptides
FR2623498B1 (fr) * 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques

Also Published As

Publication number Publication date
ATE93518T1 (de) 1993-09-15
EP0318377A2 (de) 1989-05-31
FR2623498B1 (fr) 1990-04-06
US5208255A (en) 1993-05-04
JP2537159B2 (ja) 1996-09-25
FR2623498A1 (fr) 1989-05-26
US5296509A (en) 1994-03-22
JPH02161A (ja) 1990-01-05
EP0318377B1 (de) 1993-08-25
JPH0859606A (ja) 1996-03-05
ES2059554T3 (es) 1994-11-16
US5331008A (en) 1994-07-19
JP2529172B2 (ja) 1996-08-28
EP0318377A3 (en) 1990-03-07
DE3883495D1 (de) 1993-09-30

Similar Documents

Publication Publication Date Title
ATE93518T1 (de) Enantiomere derivate von aminosaeure, verfahren zu deren herstellung und deren therapeutische verwendung.
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
ATE106860T1 (de) R-enantiomer von n-propargyl-1-aminoindan, dessen herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
ATE45728T1 (de) Verfahren zur herstellung bestimmter enantiomerenpaare von permethrinsaeure-alpha-cyano-3-phenoxy-4-fluor-b nzyl-ester.
DE3854004D1 (de) Verfahren zur Herstellung von N-substituiertem Amin.
AT385755B (de) Verfahren zur herstellung von neuen pyrensulfonsaeurederivaten
DE69004648D1 (de) Verfahren zur Herstellung von Alpha-Hydroxycarbonsäure-Amiden.
DE69004582T2 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure-Amid.
ATA292078A (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
DE3879049T2 (de) Verfahren zur Herstellung von Penizillan-Säurederivaten.
AT368502B (de) Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro(isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen
DE3776173D1 (de) Verfahren zur herstellung von saeureamiden.
DE69011758T2 (de) Verfahren zur Herstellung von N-substituierten Maleinimiden.
DE69113323T2 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure amiden.
DK574688A (da) Fremgangsmaade til fremstilling af propensyrederivater
DK498388D0 (da) Fremgangsmaade til fremstilling af propensyrederivater
ATE77378T1 (de) Verfahren zur herstellung von carbonsaeureamiden.
DK364386A (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
ATA134177A (de) Verfahren zur herstellung von racemischem und von optisch aktivem 1-tert. butylamino-3- (2',5'-dichlorphenoxy)-2-propanol und dessen saeureadditionssalzen
DK665888A (da) Fremgangsmaade til fremstilling af propansyrederivater
DE68928788T2 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DE58907865D1 (de) Verfahren zur Herstellung von alpha-Ketocarbonsäureestern.
ATE50560T1 (de) Verfahren zur herstellung von 2-acyl-3,4alkoxyanilinen.
DK152384A (da) Fremgangsmaade til fremstilling af to enantiomere af gamma-glutamyl-taurin, den racemiske blanding og farmaceutisk anvendelige salte deraf
ATE77363T1 (de) Verfahren zur herstellung von dichlorbernsteinsaeuredialkylestern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: STIPPL PATENTANWAELTE, 90482 NUERNBERG